Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 9.70% is 26% below its 5-year average of 13.10%, around the middle of its 5-year range (-2.85%–18.01%).
8.32% below its 12-month average of 10.58%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 14.14%.
GROSS MARGIN
9.70%
GROSS MARGIN AVG TTM
10.58%
GROSS MARGIN AVG 3Y
14.45%
GROSS MARGIN AVG 5Y
13.10%
GROSS MARGIN AVG 10Y
12.78%
GROSS MARGIN AVG 15Y
13.62%
GROSS MARGIN AVG 20Y
16.14%
CURRENT VS TTM AVG
-8.32%
CURRENT VS 3Y AVG
-32.86%
CURRENT VS 5Y AVG
-25.96%
CURRENT VS 10Y AVG
-24.12%
CURRENT VS 15Y AVG
-28.80%
CURRENT VS 20Y AVG
-39.91%
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 819 covered companies
CURRENT VS SECTOR MEDIAN
-75.94%
vs the sector median at left
Market Cap
$5.49B
Gross Margin
53.85%
TTM Avg
55.16%
3Y Avg
56.69%
5Y Avg
56.69%
Market Cap
$5.61B
Gross Margin
-15.02%
TTM Avg
-3561.64%
3Y Avg
-7339.64%
5Y Avg
-5851.73%
Market Cap
$5.74B
Gross Margin
54.49%
TTM Avg
70.12%
3Y Avg
77.23%
5Y Avg
64.22%
Market Cap
$5.28B
Gross Margin
95.85%
TTM Avg
94.37%
3Y Avg
93.84%
5Y Avg
94.07%
Market Cap
$5.26B
Gross Margin
54.72%
TTM Avg
55.10%
3Y Avg
55.18%
5Y Avg
55.10%
Market Cap
$5.22B
Gross Margin
-6537.01%
TTM Avg
-3376.01%
3Y Avg
-7968.48%
5Y Avg
-11525.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RadNet, Inc. (RDNT) | $5.53B | 9.70% | 10.58% | 14.45% | 13.10% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.49B | 53.85% | 55.16% | 56.69% | 56.69% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -15.02% | -3561.64% | -7339.64% | -5851.73% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | 54.49% | 70.12% | 77.23% | 64.22% |
| Doximity, Inc. (DOCS)vs › | $5.30B | 88.07% | 89.65% | 88.97% | 88.20% |
| Kodiak Sciences Inc. (KOD)vs › | $5.77B | 0.00% | 0.00% | 0.00% | 0.00% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.28B | 95.85% | 94.37% | 93.84% | 94.07% |
| Sotera Health Company (SHC)vs › | $5.26B | 54.72% | 55.10% | 55.18% | 55.10% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | -6537.01% | -3376.01% | -7968.48% | -11525.78% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.18B | 0.00% | 0.00% | 0.00% | -37.83% |
Gross Margin
9.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 14.14% |
| 2026-03-31 | -2.85% |
| 2025-12-31 | 13.86% |
| 2025-09-30 | 13.86% |
| 2025-06-30 | 13.88% |
| 2025-03-31 | 3.80% |
| 2024-12-31 | 13.76% |
| 2024-09-30 | 15.04% |
| 2024-06-30 | 15.22% |
| 2024-03-31 | 10.22% |
| 2023-12-31 | 15.17% |
| 2023-09-30 | 15.01% |
| 2023-06-30 | 14.51% |
| 2023-03-31 | 9.91% |
| 2022-12-31 | 14.14% |
| 2022-09-30 | 10.31% |
| 2022-06-30 | 13.71% |
| 2022-03-31 | 7.82% |
| 2021-12-31 | 14.55% |
| 2021-09-30 | 18.01% |
| 2021-06-30 | 15.08% |
| 2021-03-31 | 10.48% |
| 2020-12-31 | 16.28% |
| 2020-09-30 | 15.53% |
| 2020-06-30 | -1.92% |
| 2020-03-31 | 5.02% |
| 2019-12-31 | 14.99% |
| 2019-09-30 | 13.09% |
| 2019-06-30 | 14.71% |
| 2019-03-31 | 10.49% |
| 2018-12-31 | 9.28% |
| 2018-09-30 | 13.89% |
| 2018-06-30 | 14.05% |
| 2018-03-31 | 6.81% |
| 2017-12-31 | 15.01% |
| 2017-09-30 | 12.96% |
| 2017-06-30 | 13.65% |
| 2017-03-31 | 10.29% |
| 2016-12-31 | 14.57% |
| 2016-09-30 | 14.20% |
| 2016-06-30 | 11.21% |
| 2016-03-31 | 9.04% |
| 2015-12-31 | 12.87% |
| 2015-09-30 | 15.71% |
| 2015-06-30 | 13.95% |
| 2015-03-31 | 6.81% |
| 2014-12-31 | 15.49% |
| 2014-09-30 | 16.87% |
| 2014-06-30 | 17.46% |
| 2014-03-31 | 14.12% |
| 2013-12-31 | 16.66% |
| 2013-09-30 | 13.37% |
| 2013-06-30 | 15.76% |
| 2013-03-31 | 13.52% |
| 2012-12-31 | 13.50% |
| 2012-09-30 | 16.97% |
| 2012-06-30 | 17.42% |
| 2012-03-31 | 16.43% |
| 2011-12-31 | 25.11% |
| 2011-09-30 | 21.94% |
| 2011-06-30 | 23.46% |
| 2011-03-31 | 20.78% |
| 2010-12-31 | 24.65% |
| 2010-09-30 | 23.88% |
| 2010-06-30 | 23.57% |
| 2010-03-31 | 20.57% |
| 2009-12-31 | 24.82% |
| 2009-09-30 | 23.60% |
| 2009-06-30 | 23.97% |
| 2009-03-31 | 24.21% |
| 2008-12-31 | 23.67% |
| 2008-09-30 | 24.42% |
| 2008-06-30 | 23.19% |
| 2008-03-31 | 22.43% |
| 2007-12-31 | 15.89% |
| 2007-09-30 | 24.23% |
| 2007-06-30 | 26.06% |
| 2007-03-31 | 23.07% |
| 2006-10-31 | 25.63% |
| 2006-07-31 | 25.36% |
| 2006-04-30 | 25.67% |
| 2006-01-31 | 24.31% |
| 2005-10-31 | 27.12% |
| 2005-07-31 | 25.95% |
| 2005-04-30 | 25.73% |
| 2005-01-31 | 21.24% |
| 2004-10-31 | 21.06% |
| 2004-07-31 | 20.24% |
| 2004-04-30 | 22.80% |
| 2004-01-31 | 25.21% |
| 2003-10-31 | 17.68% |
| 2003-07-31 | 27.32% |
| 2003-04-30 | 26.93% |
| 2003-01-31 | 24.84% |
| 2002-10-31 | 23.57% |
| 2002-07-31 | 17.48% |
